Griffiths J, Cosgrove P, Medina E, Nath A, Chen J, Adler F
Nat Commun. 2025; 16(1):2132.
PMID: 40032842
PMC: 11876604.
DOI: 10.1038/s41467-025-56279-x.
Lei H, Hu J, Zhu J, Li R, Zhao Y, Zhao Y
Front Oncol. 2025; 15:1443890.
PMID: 40027134
PMC: 11867951.
DOI: 10.3389/fonc.2025.1443890.
Ding T, Liu C, Li Z
Mol Cancer. 2025; 24(1):18.
PMID: 39815314
PMC: 11734361.
DOI: 10.1186/s12943-025-02227-8.
Nakabayashi Y, Kiuchi J, Kubota T, Ohashi T, Nishibeppu K, Imamura T
Am J Cancer Res. 2025; 14(12):5965-5986.
PMID: 39803654
PMC: 11711524.
DOI: 10.62347/JKCU5881.
Dimopoulou K, Tiniakos D, Arkadopoulos N, Foukas P
Ann Gastroenterol. 2025; 38(1):1-11.
PMID: 39802286
PMC: 11724378.
DOI: 10.20524/aog.2024.0936.
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors.
Hamakawa Y, Hirahara A, Hayashi A, Ito K, Shinohara H, Shiba A
BMC Cancer. 2025; 25(1):17.
PMID: 39762819
PMC: 11706134.
DOI: 10.1186/s12885-025-13440-5.
Lymphocyte infiltration in breast cancer: A promising prognostic indicator.
Obeagu E, Obeagu G
Medicine (Baltimore). 2024; 103(49):e40845.
PMID: 39654199
PMC: 11631027.
DOI: 10.1097/MD.0000000000040845.
Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study.
Chou C, Lin C, Li W, Lee S, Yang C, Tian Y
Virchows Arch. 2024; .
PMID: 39592484
DOI: 10.1007/s00428-024-03974-7.
Event-free survival in neuroblastoma with MYCN amplification and deletion of 1p or 11q may be associated with altered immune status.
Wei Z, Gong B, Li X, Chen C, Zhao Q
BMC Cancer. 2024; 24(1):1279.
PMID: 39407175
PMC: 11481459.
DOI: 10.1186/s12885-024-13044-5.
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies.
Guo H, Xu X, Zhang J, Du Y, Yang X, He Z
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204153
PMC: 11357454.
DOI: 10.3390/ph17081048.
Bioinformatics analysis of the association between obesity and gastric cancer.
Ma X, Cui M, Guo Y
Front Genet. 2024; 15:1385559.
PMID: 39011399
PMC: 11246963.
DOI: 10.3389/fgene.2024.1385559.
The roles of tertiary lymphoid structures in genitourinary cancers: molecular mechanisms, therapeutic strategies, and clinical applications.
Yang J, Xiong X, Zheng W, Xu H, Liao X, Wei Q
Int J Surg. 2024; 110(8):5007-5021.
PMID: 38978471
PMC: 11325987.
DOI: 10.1097/JS9.0000000000001939.
Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence.
Zaakouk M, Longworth A, Hunter K, Jiman S, Kearns D, El-Deftar M
Int J Mol Sci. 2024; 25(12).
PMID: 38928207
PMC: 11203983.
DOI: 10.3390/ijms25126501.
Enhancing AI Research for Breast Cancer: A Comprehensive Review of Tumor-Infiltrating Lymphocyte Datasets.
Fiorin A, Lopez Pablo C, Lejeune M, Hamza Siraj A, Della Mea V
J Imaging Inform Med. 2024; 37(6):2996-3008.
PMID: 38806950
PMC: 11612116.
DOI: 10.1007/s10278-024-01043-8.
The Immune Response of Cutaneous Basosquamous- and Squamous-Cell Carcinoma Associated with Sun Exposure.
Grigore A, Oproiu A, Iancu I, Florescu I
Curr Oncol. 2024; 31(5):2481-2487.
PMID: 38785466
PMC: 11120243.
DOI: 10.3390/curroncol31050185.
Tea intake and lung diseases: a Mendelian randomization study.
Wu Z, Jiao M, Shu C, Li C, Zhu Y
Front Immunol. 2024; 15:1328933.
PMID: 38375474
PMC: 10875148.
DOI: 10.3389/fimmu.2024.1328933.
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.
Wang L, Xiao Y, Luo Y, Master R, Mo J, Kim M
J Exp Med. 2024; 221(3).
PMID: 38334978
PMC: 10857906.
DOI: 10.1084/jem.20231519.
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context.
Chia T, Billingham L, Boland L, Katz J, Arrieta V, Shireman J
Front Immunol. 2024; 14:1331287.
PMID: 38299146
PMC: 10827847.
DOI: 10.3389/fimmu.2023.1331287.
Gene set correlation enrichment analysis for interpreting and annotating gene expression profiles.
Chang L, Lee M, Wu Y, Lee W, Ma C, Chang J
Nucleic Acids Res. 2023; 52(3):e17.
PMID: 38096046
PMC: 10853793.
DOI: 10.1093/nar/gkad1187.
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer.
Wang H, Yang S, Chen L, Li Y, He P, Wang G
Bioact Mater. 2023; 33:174-222.
PMID: 38034499
PMC: 10684566.
DOI: 10.1016/j.bioactmat.2023.10.004.